Company: BLND
Filing Date: 2025-03-13
Form Type: 10-K
Source: 0001855747-25-000017
Chunk: 86

Company: Blend Labs, Inc.
Filing Date: 2025-03-13
Form: 10-K
Item: Item 8
Chunk 86
---
 A and Class B common stock. No shares of Class C common stock were issued and outstanding during the periods presented.

117

Blend Labs, Inc.Notes to Consolidated Financial Statements

Year Ended December 31,202420232022Class ACommonClass BCommonClass ACommonClass BCommonClass ACommonClass BCommon(In thousands, except per share data)Numerator:Net loss attributable to Blend Labs, Inc. $(42,257)$(1,088)$(171,266)$(7,427)$(681,657)$(38,515)Less: accretion of RNCI to redemption value(6,102)(157)(6,352)(275)(45,848)(2,590)Less: Accretion of Series A Preferred Stock to redemption value(10,606)(273)— — — — Net loss attributable to Blend Labs, Inc common stockholders$(58,965)$(1,518)$(177,618)$(7,702)$(727,505)$(41,105)Denominator:Weighted average common stock outstanding, basic and diluted247,546 6,375 235,015 10,191 221,638 12,523 Net loss per share attributable to Blend Labs, Inc.:$— $— Basic and diluted$(0.24)$(0.24)$(0.76)$(0.76)$(3.28)$(3.28)The following potential shares of common stock were excluded from the computation of diluted net earnings per share attributable to the Company for the periods presented because including them would have been antidilutive as the Company has reported net loss for each of the periods presented:As of December 31,202420232022(In thousands)Outstanding stock options17,300 19,946 25,337 Early exercised options subject to repurchase— 124 528 Non-plan Co-Founder and Head of Blend options26,057 26,057 26,057 Unvested restricted stock units13,770 20,137 12,392 Unvested performance stock awards(1)3,525 5,500 — Series G Warrant598 598 598 Haveli Warrant11,111 — — Series A redeemable convertible preferred stock46,154 — — Total anti-dilutive securities118,515 72,362 64